BRIEF-Arena Pharmaceuticals, Eisai receive 'paragraph IV certification' By: Reuters: Company News August 25, 2016 at 06:20 AM EDT * Co and Eisai Inc have received a 'paragraph IV certification' notification with respect to patents for Belviq Read More >>